Related Experiment Video
Updated: Jan 30, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Polymyxin B clinical outcomes: A prospective study of patients undergoing intravenous treatment
Karen P H Mattos1, Isabela R Gouvêa2, Júlia C F Quintanilha1
1Faculty of Medical Sciences, University of Campinas, Campinas, SP, Brazil.
What Is Known And Objective:
Polymyxins, especially polymyxin B, has become the last line of therapy against Gram-negative pathogens' carbapenemase producers. However, given increasing use of polymyxin B in clinical settings its therapeutic value has been evaluated worldwide due to its toxic effects. The aim of this study was to assess the efficacy and safety of antimicrobial therapy with polymyxin B in patients with multidrug-resistant bacteria in Brazil.
Methods:
This was a prospective cohort study in a 403-bed academic tertiary care centre, located in the countryside of Brazil. Patients receiving polymyxin B intravenous treatment for at least 72 hours were eligible for the study. Antimicrobial susceptibility, adverse reactions and clinical outcomes were submitted for descriptive analysis. Main outcomes measure the following: Patients' conditions following treatment (Treatment Success, Mortality, Treatment Failure, Inadequate Empiric Treatment or Indeterminate Response) and toxicities induced by polymyxin B (nephrotoxicity and skin hyperpigmentation).
Results And Discussion:
Among 247 patients, treatment success was achieved in 25.1%, while mortality was observed in 32.8%. Empirical therapy was prescribed for 26.3% of the patients. Nephrotoxicity was reported in 40.5%. The carbapenemase producer, Klebsiella pneumonia, was the bacterium most associated with mortality (22.2%).
Conclusions:
Even though polymyxin B is currently the main therapy against carbapenemase producers, its use demands robust criteria to lead to positive clinical outcomes.
Insights
Polymyxin B is a critical treatment for multidrug-resistant Gram-negative infections, but its clinical use in Brazil showed a low success rate (25.1%) and significant nephrotoxicity (40.5%). Careful patient selection is crucial for effective outcomes.
Area of Science:
- Infectious Diseases
- Pharmacology
- Clinical Medicine
Background:
- Polymyxins, particularly polymyxin B, are vital last-resort treatments for carbapenemase-producing Gram-negative pathogens.
- Increasing clinical use of polymyxin B necessitates evaluation of its therapeutic value due to associated toxicities.
Purpose of the Study:
- To evaluate the efficacy and safety of polymyxin B antimicrobial therapy in Brazilian patients with multidrug-resistant bacterial infections.
Main Methods:
- A prospective cohort study was conducted at a tertiary care center in Brazil.
- Included patients received intravenous polymyxin B for at least 72 hours.
- Assessed antimicrobial susceptibility, adverse reactions (nephrotoxicity, skin hyperpigmentation), and clinical outcomes (treatment success, mortality, failure).
Main Results:
- Treatment success was achieved in 25.1% of 247 patients; mortality was 32.8%.
- Nephrotoxicity occurred in 40.5% of patients.
- Klebsiella pneumoniae, a carbapenemase producer, was most frequently linked to mortality (22.2%).
Conclusions:
- Polymyxin B remains a primary therapy for carbapenemase-producing bacteria.
- Its clinical application requires stringent criteria to optimize positive patient outcomes and mitigate risks.
More Related Videos
Related Concept Videos
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Predicting Reaction Outcomes
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Hypertension III: Clinical Manifestations and Diagnostic Studies

